共 50 条
- [1] Pembrolizumab-Induced Immune-Mediated Colitis in a Patient with Concurrent Clostridium Difficile Infection [J]. CASE REPORTS IN ONCOLOGY, 2019, 12 (01): : 164 - 170
- [2] Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 2385 - 2388
- [5] A Rare Case of Refractory Immune Checkpoint Inhibitor Colitis Complicated by Concurrent Clostridioides difficile Infection [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1495 - S1495
- [6] A case of refractory immune checkpoint inhibitor-induced colitis with Clostridioides difficile infection [J]. DEN OPEN, 2023, 3 (01):
- [8] Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review [J]. MEDICINA-LITHUANIA, 2024, 60 (09):